NCT02534649
Bergonie Institut Profiling : Fighting Cancer by Matching Molecular Alterations and Drugs in Early Phase Trials
레지스트리 요약
- 진행 상태
- 모집중 (RECRUITING)
- 질환/조건
- Solid Tumor, Hematological Malignancy
- 시험 유형
- 중재 연구 (INTERVENTIONAL)
- 단계
- 해당 없음(NA)
- 목적
- 진단
- 중재 유형
- 시술·수술
- 개입·치료
- Newly obtained biopsy and Blood samples collection
- Lead Sponsor
- Institut Bergonié (기타)
캐시 시각: 2026-10-09 01:26:55
요약
This is a biology driven, monocentric study designed to identify actionable molecular alterations in cancer patients with advanced disease.
In this trial, high throughput analysis will be carried out using next generation sequencing, and immunological profiling.
Patients included in the BIP study and for whom a targetable genomic alteration had been identified might be subsequently included in an early phase trials running at Institut Bergonie or another French hospital.
In this trial, high throughput analysis will be carried out using next generation sequencing, and immunological profiling.
Patients included in the BIP study and for whom a targetable genomic alteration had been identified might be subsequently included in an early phase trials running at Institut Bergonie or another French hospital.
카카오 로그인 후 의뢰